Schrodinger, Inc. (SDGR)
Health Care / Health Care Services
S&P SmallCap 600$11.55
Scores poorly across most models. Proceed with caution.
Avoid
Score based on 3 of 5 models — moderate confidence
Is Schrodinger, Inc. a Good Investment in 2026?
Schrodinger, Inc. (SDGR) scores 1.5 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Piotroski model is the most favorable, rating Schrodinger, Inc. as Neutral. However, the Graham model rates it Caution. Schrodinger, Inc. ranks #1110 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Currently unprofitable — fair value estimate not available.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Neutral
4/9
Buffett
Caution
Business quality & competitive moat
Graham
Caution
Price vs intrinsic value
Lynch
Limited Data
Growth rate vs price (PEG)
Greenblatt
Limited Data
Earnings yield + return on capital
Frequently Asked Questions
Is Schrodinger, Inc. (SDGR) a good investment?
What is Schrodinger, Inc.'s Piotroski F-Score?
Is SDGR overvalued or undervalued?
How does SDGR compare to other Health Care stocks?
What do investment models say about SDGR?
Similar Stocks
Compare SDGR with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer